FDA approves Gardasil 9 for prevention of cancers caused by five additional types of HPV
The U.S. Food and Drug Administration today approved Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) for the prevention of certain diseases caused by nine types of Human Papillomavirus (HPV). Covering nine HPV types, five more HPV types than Gardasil (previously approved by the FDA), Gardasil 9 has the potential to prevent approximately 90 percent of cervical, vulvar, vaginal and anal cancers.
Thanks to Russell Kightley Media for the cervical cancer graphic
Source: www.fda.gov
See on Scoop.it – Virology and Bioinformatics from Virology.ca
